Best Momentum Stocks to Buy for May 9th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 9^th:

BioCryst Pharmaceuticals, Inc. BCRX: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 285.7% over the last 60 days.

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote

BioCryst’s shares gained 15% over the last three months compared with the S&P 500’s decline of 7.2%. The company possesses a Momentum Score  of A.

BioCryst Pharmaceuticals, Inc. Price

BioCryst Pharmaceuticals, Inc. price | BioCryst Pharmaceuticals, Inc. Quote

WidePoint Corporation WYY: This company that provides technology management as a service (TMaaS) has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 108.3% overthe last 60 days.

WidePoint Corporation Price and Consensus

WidePoint Corporation price-consensus-chart | WidePoint Corporation Quote

WidePoint’s shares gained 35.7% over the last three months compared with the S&P 500’s decline of 7.2%. The company possesses a Momentum Score of B.

WidePoint Corporation Price

WidePoint Corporation price | WidePoint Corporation Quote

Rambus Inc. RMBS: This semiconductor products company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.9% overthe last 60 days.

Rambus, Inc. Price and Consensus

Rambus, Inc. price-consensus-chart | Rambus, Inc. Quote

Rambus’ shares gained 11.6% over the past month compared with the S&P 500’s advance of 6.9%. The company possesses a Momentum Score of B.

Rambus, Inc. Price

Rambus, Inc. price | Rambus, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research